BPC-157 + TB-500 is a research peptide blend combining two synthetic peptides studied in laboratory research involving peptide chemistry, molecular signaling, protein interactions, cellular communication, and controlled experimental models
Until well-designed human trials are conducted and published, BPC-157 should not be recommended for clinical use in musculoskeletal medicine
Research shows improved healing outcomes in skin wounds, burns, and surgical incisions
Research in APP/PS1 Alzheimer's mice demonstrates that Dihexa treatment markedly reduces activation of astrocytes and microglia, the brain's primary inflammatory cells
Poor balance and coordination: Trouble with balance and coordination, leading to unsteady movements